Evidence map›Paper›PMID 22813429›Full record

Trial reportNeuropsychologia2013

Time, action and psychosis: using subjective time to investigate the effects of ketamine on sense of agency.

J W Moore, V C Cambridge, H Morgan, F Giorlando, R Adapa, P C Fletcher

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  10. Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

J W MooreDepartment of Psychiatry, Brain Mapping Unit, University of Cambridge, Cambridge, UK. j.moore@gold.ac.uk
V C Cambridge
H Morgan
F Giorlando
R Adapa
P C Fletcher
Goldsmiths University of London · GBUniversity of Cambridge · GBAddenbrooke's Hospital · GBUniversity of Melbourne · AU

Funding

Medical Research Council G0001354Wellcome Trust 095692
6 · The paper itself

Abstract

Sense of agency refers to the experience of initiating and controlling actions in order to influence events in the outside world. A disturbed sense of agency is found in certain psychiatric and neurological disorders, most notably schizophrenia. Sense of agency is associated with a subjective compression of time: actions and their outcomes are perceived as bound together in time. This is known as 'intentional binding' and, in healthy adults, depends partly on advance prediction of action outcomes. Notably, this predictive contribution is disrupted in patients with schizophrenia. In the present study we aimed to characterise the psychotomimetic effect of ketamine, a drug model for psychosis, on the predictive contribution to intentional binding. It was shown that ketamine produced a disruption that closely resembled previous data from patients in the early, prodromal, stage of schizophrenic illness. These results are discussed in terms of established models of delusion formation in schizophrenia. The link between time and agency, more generally, is also considered.

Indexed as

Dose-Response Relationship, DrugDouble-Blind MethodExcitatory Amino Acid AntagonistsFemaleHumansIntentionJudgmentKetamineMaleNeuropsychological TestsPredictive Value of TestsPsychiatric Status Rating ScalesPsychotic DisordersSensationYoung AdultExcitatory Amino Acid AntagonistsKetamine

Identifiers

PMID22813429
PMCPMC3562439
OpenAlexW1979913612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.